OTCMKTS:TBPMF Tetra Bio-Pharma (TBPMF) Stock Price, News & Analysis → Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (From Banyan Hill Publishing) (Ad) Free TBPMF Stock Alerts $0.0002 0.00 (0.00%) (As of 09/18/2023) Add Compare Share Share Today's Range$0.0002▼$0.000650-Day Range N/A52-Week Range$0.0002▼$0.0006Volume15,300 shsAverage Volume185,753 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Tetra Bio-Pharma alerts: Email Address Ad DTIA new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… Click here to see me place one of these trades LIVE on camera. About Tetra Bio-Pharma Stock (OTCMKTS:TBPMF)Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.Read More TBPMF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TBPMF Stock News HeadlinesMarch 16, 2024 | benzinga.comLatest News for First Wave BioPharma Stock (NASDAQ:FWBI)August 1, 2023 | seekingalpha.comTetra Bio-Pharma files for bankruptcy in CanadaApril 29, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… May 12, 2023 | marketwatch.comTetra Bio-Pharma Cancels New Drug Submission to Health CanadaApril 28, 2023 | theglobeandmail.comClosing Bell: Tetra Bio Pharma Inc flat on Wednesday (TBP)April 27, 2023 | theglobeandmail.comClosing Bell: Tetra Bio Pharma Inc flat on Tuesday (TBP)April 25, 2023 | theglobeandmail.comClosing Bell: Tetra Bio Pharma Inc flat on Monday (TBP)April 18, 2023 | theglobeandmail.comClosing Bell: Tetra Bio Pharma Inc flat on Friday (TBP)April 29, 2024 | DTI (Ad)A new way to collect income from stocksMost people think of BUYING options when they talk about options. It’s how speculators leverage large sums of money hoping that a stock moves in the “right” direction over a certain period of time. The problem is - they don’t always pay off when you buy them. In fact, a contributing writer at the Financial Post studied options extensively… April 15, 2023 | theglobeandmail.comClosing Bell: Tetra Bio Pharma Inc flat on Thursday (TBP)April 9, 2023 | theglobeandmail.comClosing Bell: Tetra Bio-Pharma Inc flat on Wednesday (TBP-WT-C)March 7, 2023 | finance.yahoo.comIIROC Trading Halt - TBPMarch 3, 2023 | finance.yahoo.comTetra Bio-Pharma Receives Funding from the Government of Canada for ARDS-003March 1, 2023 | finance.yahoo.comTetra Bio-Pharma Inc. Announces a Delay in Filing 2022 Annual Financial Statements and Related Management's Discussion and AnalysisFebruary 28, 2023 | ca.finance.yahoo.comTetra Bio-Pharma Inc. (TBP.TO)February 19, 2023 | marketwatch.comBio-pharma Market 2023: A Status of Top Regions and Companies with Growth ProspectsFebruary 14, 2023 | finance.yahoo.comIIROC Trading Halt - TBP.WT.BDecember 22, 2022 | prnewswire.comREDUVO™ Marketing Approval on the Right PathDecember 6, 2022 | finance.yahoo.comTetra Bio-Pharma Announces Results of Artificial Intelligence Study of ARDS-003 Combined with FavipiravirNovember 30, 2022 | finance.yahoo.comThe Power Play by The Market Herald Releases New Interviews with Group Eleven, iMining, Gamelancer, Cassiar Gold, ApartmentLove, Tetra Bio-Pharma and Sitka Gold Discussing Their Latest NewsNovember 29, 2022 | finance.yahoo.comTetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003October 28, 2022 | benzinga.comTetra Bio-Pharma Anounces Second Closing Of Financing With Alpha Blue OceanOctober 28, 2022 | msn.comTetra Bio-Pharma Announces Second Closing Of Financing With Alpha Blue OceanOctober 27, 2022 | finance.yahoo.comTetra Bio-Pharma Inc. Announces Second Closing of Financing with Alpha Blue OceanOctober 13, 2022 | marketwatch.comTetra Bio-Pharma Inc. (TBPMF) and Prepaire Jointly Apply to BARDA for FundingOctober 11, 2022 | finance.yahoo.comTetra and Prepaire Jointly Apply to BARDA for FundingSeptember 8, 2022 | finance.yahoo.comTetra Bio-Pharma Inc. Announces Revised Terms and First Closing of Financing with Alpha Blue OceanSee More Headlines Receive TBPMF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tetra Bio-Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:TBPMF CUSIPN/A CIKN/A Webwww.tetrabiopharma.com Phone(833) 977-7575FaxN/AEmployees33Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Guy Chamberland M.Sc. (Age 61)Master Herbal, Co-Founder, CEO, Chief Regulatory Officer & Director Comp: $239.98kMr. Steeve NéronChief Commercial OfficerMr. André Rancourt B.Sc.Co-FounderMs. Leslie Auld CPAM.B.A., Chief Financial OfficerJennifer McCaugheyVP of Investor RelationsMs. Dania Scott B.Sc.Sr. VP of Commercial StrategyMs. Aurelia De PauwSr. VP of Clinical Programs & Medical AffairsMr. Richard GiguereChief Exec. Officer of Tetra Natural Health Inc.Randy RinguetteProject Director & Member of Advisory BoardMr. Chris MacLeanChief Operating Officer of Tetra Natural HealthMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors TBPMF Stock Analysis - Frequently Asked Questions How have TBPMF shares performed in 2024? Tetra Bio-Pharma's stock was trading at $0.0006 on January 1st, 2024. Since then, TBPMF shares have decreased by 66.7% and is now trading at $0.0002. View the best growth stocks for 2024 here. How do I buy shares of Tetra Bio-Pharma? Shares of TBPMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:TBPMF) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHis win rate puts Warren Buffett to shame… Investing DailyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tetra Bio-Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
